Stanford Hypertrophic Cardiomyopathy Center:
Leaders in Specialized Care and Expertise

by Mary Sheridan Bilbao, PA-C, MPAS
February 27, 2024

The Stanford Hypertrophic Cardiomyopathy Center is recognized as a Hypertrophic Cardiomyopathy Association Center of Excellence and offers specialized care for patients with hypertrophic cardiomyopathy (HCM). Stanford has received this prestigious recognition every year since 2010. With a dedicated multidisciplinary team comprising cardiologists, surgeons, radiologists, anesthesiologists, electrophysiologists, genetic counselors, and other allied health professionals, the center delivers high-quality care tailored to each patient's unique needs. Leveraging Stanford's extensive expertise and experience in managing a substantial volume of HCM cases, the center provides patients with access to resources and knowledge specific to their conditions.

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterized by abnormal thickening and stiffness of the heart muscle, typically in the ventricular septum—the wall between the heart's chambers. This thickening often obstructs blood flow from the heart, leading to symptoms like fatigue, shortness of breath, and chest pain. Some individuals with HCM may also have concurrent mitral valve disease, exacerbating blood flow obstruction. Moreover, HCM patients are at increased risk of life-threatening abnormal heart rhythms. For those seeking comprehensive information on HCM, treatment options, and the opportunity to meet Stanford's multidisciplinary team, the center's latest video provides valuable insights and resources.

Visit the CT Surgery Hypertrophic Cardiomyopathy webpage for more information about our team, HCM, surgical treatment, and options.